Ken Shimamoto

2.0k total citations
37 papers, 399 citations indexed

About

Ken Shimamoto is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ken Shimamoto has authored 37 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Ken Shimamoto's work include Cardiovascular Function and Risk Factors (9 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Cardiac Imaging and Diagnostics (4 papers). Ken Shimamoto is often cited by papers focused on Cardiovascular Function and Risk Factors (9 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Cardiac Imaging and Diagnostics (4 papers). Ken Shimamoto collaborates with scholars based in Japan. Ken Shimamoto's co-authors include Noboru Kaneko, Ryuko Matsuda, Masatoshi Kawana, Osamu Iimura, Rieko Sakai, Hisashi Hasumi, Migaku Kikuchi, Haruki Sekiguchi, Fumiko Chiwaki and Mayumi Shimizu and has published in prestigious journals such as PLoS ONE, Water Research and CHEST Journal.

In The Last Decade

Ken Shimamoto

36 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Shimamoto Japan 13 221 138 64 44 39 37 399
Gary Gong United States 13 134 0.6× 92 0.7× 83 1.3× 76 1.7× 82 2.1× 32 377
Xavier Waintraub France 15 537 2.4× 183 1.3× 53 0.8× 46 1.0× 40 1.0× 48 763
Н. Ш. Загидуллин Russia 12 193 0.9× 275 2.0× 133 2.1× 44 1.0× 37 0.9× 95 631
Branislav Líška Slovakia 11 82 0.4× 112 0.8× 138 2.2× 28 0.6× 22 0.6× 25 316
N. Banchieri Italy 10 287 1.3× 261 1.9× 40 0.6× 69 1.6× 93 2.4× 10 542
Jenö E. Szakács United States 7 148 0.7× 72 0.5× 88 1.4× 45 1.0× 37 0.9× 11 356
Ronald Vlasblom Netherlands 8 245 1.1× 223 1.6× 161 2.5× 31 0.7× 114 2.9× 10 562
Liangping Zhao China 12 73 0.3× 180 1.3× 61 1.0× 58 1.3× 78 2.0× 26 434
Xiaopeng Li China 7 173 0.8× 162 1.2× 26 0.4× 108 2.5× 57 1.5× 17 413
Chengfu Cao China 11 88 0.4× 220 1.6× 59 0.9× 16 0.4× 38 1.0× 25 415

Countries citing papers authored by Ken Shimamoto

Since Specialization
Citations

This map shows the geographic impact of Ken Shimamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Shimamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Shimamoto more than expected).

Fields of papers citing papers by Ken Shimamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Shimamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Shimamoto. The network helps show where Ken Shimamoto may publish in the future.

Co-authorship network of co-authors of Ken Shimamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Shimamoto. A scholar is included among the top collaborators of Ken Shimamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Shimamoto. Ken Shimamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arimura, Ken, Etsuko Tagaya, Ken Kikuchi, et al.. (2022). The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19. Transplant Immunology. 77. 101777–101777. 1 indexed citations
3.
Kimura, Makiko, Haruki Sekiguchi, Ken Shimamoto, et al.. (2022). High-normal diastolic blood pressure as a risk factor for left ventricular diastolic dysfunction in healthy postmenopausal women. Hypertension Research. 45(12). 1891–1898. 1 indexed citations
4.
Suzuki, Mayumi, Ken Shimamoto, Haruki Sekiguchi, et al.. (2018). Arousal index as a marker of carotid artery atherosclerosis in patients with obstructive sleep apnea syndrome. Sleep And Breathing. 23(1). 87–94. 13 indexed citations
5.
Sekiguchi, Haruki, Kentaro Jujo, Kazunori Iwade, et al.. (2017). Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function. Kidney International Reports. 3(1). 65–72. 6 indexed citations
6.
Sekiguchi, Haruki, Ken Shimamoto, Yuri Ozaki, et al.. (2015). Gender Differences in Predictors of Left Ventricular Myocardial Relaxation in Non-Obese, Healthy Individuals. PLoS ONE. 10(4). e0125107–e0125107. 1 indexed citations
7.
Sekiguchi, Haruki, Yoshihito Uchida, Issei Ishida, et al.. (2013). Oxygen preconditioning prevents contrast-induced nephropathy in patients with chronic kidney disease: option CIN-CKD Randomized Trial. European Heart Journal. 34(suppl 1). P4298–P4298.
8.
Kaneko, Noboru, et al.. (2010). Three-dimensional reconstruction of the human capillary network and the intramyocardial micronecrosis. American Journal of Physiology-Heart and Circulatory Physiology. 300(3). H754–H761. 44 indexed citations
9.
Kaneko, Noboru, et al.. (2009). Pharmacological Characteristics and Clinical Applications of K201. Current Clinical Pharmacology. 4(2). 126–131. 37 indexed citations
10.
Shimamoto, Ken, et al.. (2009). Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide. BMC Cardiovascular Disorders. 9(1). 2–2. 4 indexed citations
11.
Shimamoto, Ken, et al.. (2007). Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation. Canadian Journal of Cardiology. 23(4). 295–300. 16 indexed citations
12.
Hasumi, Hisashi, et al.. (2006). K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. European Journal of Pharmacology. 555(1). 54–60. 22 indexed citations
13.
Shimamoto, Ken, et al.. (2006). An .ALPHA.1-Receptor Blocker Reduces Plasma Leptin Levels in Hypertensive Patients with Obesity and Hyperleptinemia. Hypertension Research. 29(10). 805–811. 14 indexed citations
14.
Kaneko, Noboru, et al.. (2006). Norepinephrine-induced diastolic dysfunction with aortic valve opening under calcium-loading in rats. Drug Development Research. 67(6). 511–518. 7 indexed citations
15.
Matsuda, Ryuko, Noboru Kaneko, Migaku Kikuchi, et al.. (2003). Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room. Resuscitation. 57(2). 171–177. 37 indexed citations
16.
Ogihara, Toshio, Masayuki Matsumoto, Hiroyuki Matsuoka, et al.. (1999). Guidelines on Treatment of Hypertension in the elderly. 1999 Revised Version.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 36(8). 576–603. 4 indexed citations
17.
Kaneko, Noboru, et al.. (1997). Inhibition of annexin V-dependent Ca2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1330(1). 1–7. 46 indexed citations
18.
Yamaguchi, Jun, et al.. (1995). A Clinical and Pathological Study of 46 Cases of Sudden and Unexpected Death.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 32(11). 722–727. 3 indexed citations
19.
Shimamoto, Ken, et al.. (1994). Left-Sided Unilateral Pulmonary Edema in Postinfarction Ventricular Septal Rupture. CHEST Journal. 105(4). 1264–1265. 13 indexed citations
20.
Shimamoto, Ken & Osamu Iimura. (1987). Measurement of Circulating Kinins, Their Changes by Inhibition of Kininase II and Their Possible Blood Pressure Lowering Effect. Birkhäuser Basel eBooks. 22. 297–307. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Gong Breakdown of academic impact, for papers by Xavier Waintraub Breakdown of academic impact, for papers by Н. Ш. Загидуллин Breakdown of academic impact, for papers by Branislav Líška Breakdown of academic impact, for papers by N. Banchieri Breakdown of academic impact, for papers by Jenö E. Szakács Breakdown of academic impact, for papers by Ronald Vlasblom Breakdown of academic impact, for papers by Liangping Zhao Breakdown of academic impact, for papers by Xiaopeng Li Breakdown of academic impact, for papers by Chengfu Cao
Rankless by CCL
2026